Sandbox:Eiman: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{| | {| | ||
! colspan="2" rowspan="3 | ! colspan="2" rowspan="3" |Etiology | ||
! colspan="10" style="background:#4479BA; color: #FFFFFF;" |Clinical manifestations | ! colspan="10" style="background:#4479BA; color: #FFFFFF;" |Clinical manifestations | ||
! colspan="11" style="background:#4479BA; color: #FFFFFF;" |Paraclinical findings | ! colspan="11" style="background:#4479BA; color: #FFFFFF;" |Paraclinical findings | ||
Line 36: | Line 36: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Other | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Other | ||
|- | |- | ||
! rowspan=" | ! rowspan="15" |Prerenal | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alcohol poisoning]]<ref name="pmid15589492">{{cite journal |vauthors=Pletcher MJ, Maselli J, Gonzales R |title=Uncomplicated alcohol intoxication in the emergency department: an analysis of the National Hospital Ambulatory Medical Care Survey |journal=Am. J. Med. |volume=117 |issue=11 |pages=863–7 |date=December 2004 |pmid=15589492 |doi=10.1016/j.amjmed.2004.07.042 |url=}}</ref><ref name="pmid2927129">{{cite journal |vauthors=Cherpitel CJ |title=Breath analysis and self-reports as measures of alcohol-related emergency room admissions |journal=J. Stud. Alcohol |volume=50 |issue=2 |pages=155–61 |date=March 1989 |pmid=2927129 | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alcohol poisoning]]<ref name="pmid15589492">{{cite journal |vauthors=Pletcher MJ, Maselli J, Gonzales R |title=Uncomplicated alcohol intoxication in the emergency department: an analysis of the National Hospital Ambulatory Medical Care Survey |journal=Am. J. Med. |volume=117 |issue=11 |pages=863–7 |date=December 2004 |pmid=15589492 |doi=10.1016/j.amjmed.2004.07.042 |url=}}</ref><ref name="pmid2927129">{{cite journal |vauthors=Cherpitel CJ |title=Breath analysis and self-reports as measures of alcohol-related emergency room admissions |journal=J. Stud. Alcohol |volume=50 |issue=2 |pages=155–61 |date=March 1989 |pmid=2927129 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |+ | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |- | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |+/- | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |- | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |+/- | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |+ | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |+/- | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |- | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |- | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |- | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[PT]] | | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[PT]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]] (isopropyl [[alcohol]]) | | style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]] (isopropyl [[alcohol]]) | ||
Line 58: | Line 58: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |- | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Thiamine]] must be given to prevent [[Wernicke's encephalopathy]] | | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Thiamine]] must be given to prevent [[Wernicke's encephalopathy]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Aspergillosis|'''Aspergillosis''']]<ref name="pmid11880955">{{cite journal |vauthors=Marr KA, Carter RA, Crippa F, Wald A, Corey L |title=Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients |journal=Clin. Infect. Dis. |volume=34 |issue=7 |pages=909–17 |date=April 2002 |pmid=11880955 |doi=10.1086/339202 |url=}}</ref><ref name="pmid16886149">{{cite journal |vauthors=Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupée M, Caulet-Maugendre S, Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP |title=Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey |journal=Clin. Infect. Dis. |volume=43 |issue=5 |pages=577–84 |date=September 2006 |pmid=16886149 |doi=10.1086/505870 | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Aspergillosis|'''Aspergillosis''']]<ref name="pmid11880955">{{cite journal |vauthors=Marr KA, Carter RA, Crippa F, Wald A, Corey L |title=Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients |journal=Clin. Infect. Dis. |volume=34 |issue=7 |pages=909–17 |date=April 2002 |pmid=11880955 |doi=10.1086/339202 |url=}}</ref><ref name="pmid16886149">{{cite journal |vauthors=Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupée M, Caulet-Maugendre S, Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP |title=Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey |journal=Clin. Infect. Dis. |volume=43 |issue=5 |pages=577–84 |date=September 2006 |pmid=16886149 |doi=10.1086/505870 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | ||
Line 82: | Line 82: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Halo sign, Wedge-shaped pulmonary [[infarction]], [[Granuloma]] | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Halo sign, Wedge-shaped pulmonary [[infarction]], [[Granuloma]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |- | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Polymerase chain reaction|Polymerase chain reaction (PCR)]] | | style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Polymerase chain reaction|Polymerase chain reaction (PCR)]] | ||
|- | |- | ||
Line 109: | Line 109: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Congestive heart failure]] (CHF)<ref name="pmid17724259">{{cite journal |vauthors=Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA |title=Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure |journal=Circulation |volume=116 |issue=13 |pages=1482–7 |date=September 2007 |pmid=17724259 |doi=10.1161/CIRCULATIONAHA.107.696906 |url=}}</ref><ref name="pmid15687312">{{cite journal |vauthors=Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ |title=Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis |journal=JAMA |volume=293 |issue=5 |pages=572–80 |date=February 2005 |pmid=15687312 |doi=10.1001/jama.293.5.572 | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Congestive heart failure]] (CHF)<ref name="pmid17724259">{{cite journal |vauthors=Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA |title=Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure |journal=Circulation |volume=116 |issue=13 |pages=1482–7 |date=September 2007 |pmid=17724259 |doi=10.1161/CIRCULATIONAHA.107.696906 |url=}}</ref><ref name="pmid15687312">{{cite journal |vauthors=Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ |title=Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis |journal=JAMA |volume=293 |issue=5 |pages=572–80 |date=February 2005 |pmid=15687312 |doi=10.1001/jama.293.5.572 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | ||
Line 133: | Line 133: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Dehydration]]<ref name="pmid15187057">{{cite journal |vauthors=Steiner MJ, DeWalt DA, Byerley JS |title=Is this child dehydrated? |journal=JAMA |volume=291 |issue=22 |pages=2746–54 |date=June 2004 |pmid=15187057 |doi=10.1001/jama.291.22.2746 |url=}}</ref><ref name="pmid9220501">{{cite journal |vauthors=Vega RM, Avner JR |title=A prospective study of the usefulness of clinical and laboratory parameters for predicting percentage of dehydration in children |journal=Pediatr Emerg Care |volume=13 |issue=3 |pages=179–82 |date=June 1997 |pmid=9220501 | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Dehydration]]<ref name="pmid15187057">{{cite journal |vauthors=Steiner MJ, DeWalt DA, Byerley JS |title=Is this child dehydrated? |journal=JAMA |volume=291 |issue=22 |pages=2746–54 |date=June 2004 |pmid=15187057 |doi=10.1001/jama.291.22.2746 |url=}}</ref><ref name="pmid9220501">{{cite journal |vauthors=Vega RM, Avner JR |title=A prospective study of the usefulness of clinical and laboratory parameters for predicting percentage of dehydration in children |journal=Pediatr Emerg Care |volume=13 |issue=3 |pages=179–82 |date=June 1997 |pmid=9220501 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki> | ||
Line 157: | Line 157: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Diarrhea]] and/or [[vomiting]]<ref name="pmid2178747">{{cite journal |vauthors=Carpenter DO |title=Neural mechanisms of emesis |journal=Can. J. Physiol. Pharmacol. |volume=68 |issue=2 |pages=230–6 |date=February 1990 |pmid=2178747 |doi= |url=}}</ref><ref name="pmid22454468">{{cite journal |vauthors=Bresee JS, Marcus R, Venezia RA, Keene WE, Morse D, Thanassi M, Brunett P, Bulens S, Beard RS, Dauphin LA, Slutsker L, Bopp C, Eberhard M, Hall A, Vinje J, Monroe SS, Glass RI |title=The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States |journal=J. Infect. Dis. |volume=205 |issue=9 |pages=1374–81 |date=May 2012 |pmid=22454468 |doi=10.1093/infdis/jis206 | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Diarrhea]] and/or [[vomiting]]<ref name="pmid2178747">{{cite journal |vauthors=Carpenter DO |title=Neural mechanisms of emesis |journal=Can. J. Physiol. Pharmacol. |volume=68 |issue=2 |pages=230–6 |date=February 1990 |pmid=2178747 |doi= |url=}}</ref><ref name="pmid22454468">{{cite journal |vauthors=Bresee JS, Marcus R, Venezia RA, Keene WE, Morse D, Thanassi M, Brunett P, Bulens S, Beard RS, Dauphin LA, Slutsker L, Bopp C, Eberhard M, Hall A, Vinje J, Monroe SS, Glass RI |title=The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States |journal=J. Infect. Dis. |volume=205 |issue=9 |pages=1374–81 |date=May 2012 |pmid=22454468 |doi=10.1093/infdis/jis206 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | ||
Line 231: | Line 231: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Heart disease]]<ref name="pmid2030718">{{cite journal |vauthors=LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH |title=Smoking and mortality among older men and women in three communities |journal=N. Engl. J. Med. |volume=324 |issue=23 |pages=1619–25 |date=June 1991 |pmid=2030718 |doi=10.1056/NEJM199106063242303 |url=}}</ref><ref name="pmid19581259">{{cite journal |vauthors=Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, Gidding SS, Beekman RH, Grosse SD |title=Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP |journal=Pediatrics |volume=124 |issue=2 |pages=823–36 |date=August 2009 |pmid=19581259 |doi=10.1542/peds.2009-1397 |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Heart disease]]<ref name="pmid2030718">{{cite journal |vauthors=LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH |title=Smoking and mortality among older men and women in three communities |journal=N. Engl. J. Med. |volume=324 |issue=23 |pages=1619–25 |date=June 1991 |pmid=2030718 |doi=10.1056/NEJM199106063242303 |url=}}</ref><ref name="pmid19581259">{{cite journal |vauthors=Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, Gidding SS, Beekman RH, Grosse SD |title=Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP |journal=Pediatrics |volume=124 |issue=2 |pages=823–36 |date=August 2009 |pmid=19581259 |doi=10.1542/peds.2009-1397 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | ||
Line 257: | Line 254: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemorrhage]]<ref name="pmid21098468">{{cite journal |vauthors=Achneck HE, Sileshi B, Parikh A, Milano CA, Welsby IJ, Lawson JH |title=Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface |journal=Circulation |volume=122 |issue=20 |pages=2068–77 |date=November 2010 |pmid=21098468 |doi=10.1161/CIRCULATIONAHA.110.936773 |url=}}</ref><ref name="pmid3487361">{{cite journal |vauthors=Gralnick HR, Rick ME, McKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y |title=Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease |journal=Blood |volume=68 |issue=1 |pages=58–61 |date=July 1986 |pmid=3487361 | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemorrhage]]<ref name="pmid21098468">{{cite journal |vauthors=Achneck HE, Sileshi B, Parikh A, Milano CA, Welsby IJ, Lawson JH |title=Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface |journal=Circulation |volume=122 |issue=20 |pages=2068–77 |date=November 2010 |pmid=21098468 |doi=10.1161/CIRCULATIONAHA.110.936773 |url=}}</ref><ref name="pmid3487361">{{cite journal |vauthors=Gralnick HR, Rick ME, McKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y |title=Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease |journal=Blood |volume=68 |issue=1 |pages=58–61 |date=July 1986 |pmid=3487361 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | ||
Line 281: | Line 278: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemolysis]]<ref name="pmid3814817">{{cite journal |vauthors=Liesveld JL, Rowe JM, Lichtman MA |title=Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases |journal=Blood |volume=69 |issue=3 |pages=820–6 |date=March 1987 |pmid=3814817 |doi= |url=}}</ref><ref name="pmid7365971">{{cite journal |vauthors=Marchand A, Galen RS, Van Lente F |title=The predictive value of serum haptoglobin in hemolytic disease |journal=JAMA |volume=243 |issue=19 |pages=1909–11 |date=May 1980 |pmid=7365971 | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemolysis]]<ref name="pmid3814817">{{cite journal |vauthors=Liesveld JL, Rowe JM, Lichtman MA |title=Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases |journal=Blood |volume=69 |issue=3 |pages=820–6 |date=March 1987 |pmid=3814817 |doi= |url=}}</ref><ref name="pmid7365971">{{cite journal |vauthors=Marchand A, Galen RS, Van Lente F |title=The predictive value of serum haptoglobin in hemolytic disease |journal=JAMA |volume=243 |issue=19 |pages=1909–11 |date=May 1980 |pmid=7365971 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | ||
Line 302: | Line 299: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |- | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | - | | style="background: #F5F5F5; padding: 5px; text-align: center;" | - | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hepatorenal syndrome]]<ref name="pmid19776409">{{cite journal |vauthors=Ginès P, Schrier RW |title=Renal failure in cirrhosis |journal=N. Engl. J. Med. |volume=361 |issue=13 |pages=1279–90 |date=September 2009 |pmid=19776409 |doi=10.1056/NEJMra0809139 |url=}}</ref><ref name="pmid8550036">{{cite journal |vauthors=Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Schölmerich J |title=Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club |journal=Hepatology |volume=23 |issue=1 |pages=164–76 |date=January 1996 |pmid=8550036 |doi=10.1002/hep.510230122 | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hepatorenal syndrome]]<ref name="pmid19776409">{{cite journal |vauthors=Ginès P, Schrier RW |title=Renal failure in cirrhosis |journal=N. Engl. J. Med. |volume=361 |issue=13 |pages=1279–90 |date=September 2009 |pmid=19776409 |doi=10.1056/NEJMra0809139 |url=}}</ref><ref name="pmid8550036">{{cite journal |vauthors=Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Schölmerich J |title=Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club |journal=Hepatology |volume=23 |issue=1 |pages=164–76 |date=January 1996 |pmid=8550036 |doi=10.1002/hep.510230122 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | ||
Line 329: | Line 326: | ||
| - | | - | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cardiomyopathy|Ischemic cardiomyopathy]]<ref name="pmid16567565">{{cite journal |vauthors=Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB |title=Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention |journal=Circulation |volume=113 |issue=14 |pages=1807–16 |date=April 2006 |pmid=16567565 |doi=10.1161/CIRCULATIONAHA.106.174287 |url=}}</ref><ref name="pmid15689345">{{cite journal |vauthors=Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, Mellwig KP, Assanelli D, Delise P, van-Buuren F, Anastasakis A, Heidbuchel H, Hoffmann E, Fagard R, Priori SG, Basso C, Arbustini E, Blomstrom-Lundqvist C, McKenna WJ, Thiene G |title=Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology |journal=Eur. Heart J. |volume=26 |issue=5 |pages=516–24 |date=March 2005 |pmid=15689345 |doi=10.1093/eurheartj/ehi108 | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cardiomyopathy|Ischemic cardiomyopathy]]<ref name="pmid16567565">{{cite journal |vauthors=Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB |title=Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention |journal=Circulation |volume=113 |issue=14 |pages=1807–16 |date=April 2006 |pmid=16567565 |doi=10.1161/CIRCULATIONAHA.106.174287 |url=}}</ref><ref name="pmid15689345">{{cite journal |vauthors=Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, Mellwig KP, Assanelli D, Delise P, van-Buuren F, Anastasakis A, Heidbuchel H, Hoffmann E, Fagard R, Priori SG, Basso C, Arbustini E, Blomstrom-Lundqvist C, McKenna WJ, Thiene G |title=Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology |journal=Eur. Heart J. |volume=26 |issue=5 |pages=516–24 |date=March 2005 |pmid=15689345 |doi=10.1093/eurheartj/ehi108 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | ||
Line 353: | Line 350: | ||
| - | | - | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Liver cirrhosis]]<ref name="pmid24076364">{{cite journal |vauthors=Ge PS, Runyon BA |title=The changing role of beta-blocker therapy in patients with cirrhosis |journal=J. Hepatol. |volume=60 |issue=3 |pages=643–53 |date=March 2014 |pmid=24076364 |doi=10.1016/j.jhep.2013.09.016 |url=}}</ref><ref name="pmid3533689">{{cite journal |vauthors=Becker CD, Scheidegger J, Marincek B |title=Hepatic vein occlusion: morphologic features on computed tomography and ultrasonography |journal=Gastrointest Radiol |volume=11 |issue=4 |pages=305–11 |date=1986 |pmid=3533689 |doi= | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Liver cirrhosis]]<ref name="pmid24076364">{{cite journal |vauthors=Ge PS, Runyon BA |title=The changing role of beta-blocker therapy in patients with cirrhosis |journal=J. Hepatol. |volume=60 |issue=3 |pages=643–53 |date=March 2014 |pmid=24076364 |doi=10.1016/j.jhep.2013.09.016 |url=}}</ref><ref name="pmid3533689">{{cite journal |vauthors=Becker CD, Scheidegger J, Marincek B |title=Hepatic vein occlusion: morphologic features on computed tomography and ultrasonography |journal=Gastrointest Radiol |volume=11 |issue=4 |pages=305–11 |date=1986 |pmid=3533689 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki> | ||
Line 399: | Line 396: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Left atrial enlargement and left ventricular [[hypertrophy|hypertrophy in]] [[echocardiography]] | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Left atrial enlargement and left ventricular [[hypertrophy|hypertrophy in]] [[echocardiography]] | ||
| - | |||
|- | |||
! colspan="2" |Etiology | |||
!Fatigue/ | |||
Lethargy | |||
!Thirst | |||
!Dizziness/ | |||
Confusion | |||
!Muscle weakness/ | |||
cramp | |||
!Somatic/ | |||
visceral pain | |||
!Vomiting | |||
!Diarrhea | |||
!Tachypnea | |||
!Hematuria/ | |||
Proteinuria | |||
!Edema | |||
!Blood indices | |||
!Renal Funtion test | |||
!Electrolytes | |||
!Urine analysis | |||
!ABG | |||
!Other | |||
!Ultrasound | |||
!X-ray | |||
!CT | |||
!MRI | |||
!Other | |||
!Comments | |||
|- | |||
! | |||
|[[Myocarditis|'''Myocarditis''']]<ref name="pmid39746742">{{cite journal |vauthors=Dec GW, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA |title=Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome |journal=N. Engl. J. Med. |volume=312 |issue=14 |pages=885–90 |date=April 1985 |pmid=3974674 |doi=10.1056/NEJM198504043121404 |url=}}</ref> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|[[Leukocytosis]] ([[eosinophilia]]),↑[[ESR]] and [[CRP]] | |||
|Not applicable | |||
|Not applicable | |||
|Not applicable | |||
|Not applicable | |||
|[[Cardiac enzymes]], Viral antibodies | |||
|Not applicable | |||
|Not applicable | |||
|Not applicable | |||
|Inflammatory [[edema]], Degree of scarring | |||
|[[Endomyocardial biopsy]], [[Echocardiography]], [[Scintigraphy]] | |||
|Not applicable | |||
|- | |||
! | |||
|[[Peritonitis|'''Peritonitis''']]<ref name="pmid97980132">{{cite journal |vauthors=Such J, Runyon BA |title=Spontaneous bacterial peritonitis |journal=Clin. Infect. Dis. |volume=27 |issue=4 |pages=669–74; quiz 675–6 |date=October 1998 |pmid=9798013 |doi= |url=}}</ref><ref name="pmid22106722">{{cite journal |vauthors=Runyon BA |title=Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis |journal=Hepatology |volume=12 |issue=4 Pt 1 |pages=710–5 |date=October 1990 |pmid=2210672 |doi= |url=}}</ref> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|[[Leukocytosis]] | |||
|Not applicable | |||
|Not applicable | |||
|Not applicable | |||
|Not applicable | |||
|Ascitic fluid [[neutrophil]] count > 500 cells/µL | |||
|Not applicable | |||
|Not applicable | |||
|Not applicable | |||
|Not applicable | |||
| - | |||
| - | |||
|- | |||
! | |||
|[[Polycythemia|'''Polycythemia''']]<ref name="pmid90251652">{{cite journal |vauthors=Gregg XT, Prchal JT |title=Erythropoietin receptor mutations and human disease |journal=Semin. Hematol. |volume=34 |issue=1 |pages=70–6 |date=January 1997 |pmid=9025165 |doi= |url=}}</ref><ref name="pmid92925432">{{cite journal |vauthors=Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT |title=Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias |journal=Blood |volume=90 |issue=5 |pages=2057–61 |date=September 1997 |pmid=9292543 |doi= |url=}}</ref> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|↑[[RBC]], ↑[[Hematocrit|HCT]], ↑[[Hemoglobin|HGB]], [[Thrombocytosis]], [[Leukocytosis]], ↑[[PT]] and [[aPTT]] | |||
|↓[[Erythropoietin]] | |||
|Not applicable | |||
|Not applicable | |||
|Not applicable | |||
|[[Hyperuricemia]] | |||
|[[Splenomegaly]] | |||
|Not applicable | |||
|Not applicable | |||
|Not applicable | |||
| - | |||
|[[Phlebotomy]] is the usual treatment | |||
|- | |||
! | |||
|[[Respiratory distress syndrome|'''Respiratory distress syndrome''']]<ref name="pmid265428772">{{cite journal |vauthors=Hooper SB, Te Pas AB, Kitchen MJ |title=Respiratory transition in the newborn: a three-phase process |journal=Arch. Dis. Child. Fetal Neonatal Ed. |volume=101 |issue=3 |pages=F266–71 |date=May 2016 |pmid=26542877 |doi=10.1136/archdischild-2013-305704 |url=}}</ref> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|Not applicable | |||
|Not applicable | |||
|Not applicable | |||
|Not applicable | |||
|[[Metabolic acidosis|Metabolic]] and [[Metabolic acidosis|respiratory acidosis]] | |||
|[[Pulse oximetry]] | |||
|Not applicable | |||
|Bilateral, diffuse, reticular granular or ground-glass appearance +/- [[Cardiomegaly]] | |||
|Not applicable | |||
|Not applicable | |||
|[[Patent ductus arteriosus]] [[hypertrophy|in]] [[echocardiography]] | |||
| - | |||
|- | |||
! | |||
|[[Shock|'''Shock''']]<ref name="pmid24171518">{{cite journal |vauthors=Vincent JL, De Backer D |title=Circulatory shock |journal=N. Engl. J. Med. |volume=369 |issue=18 |pages=1726–34 |date=October 2013 |pmid=24171518 |doi=10.1056/NEJMra1208943 |url=}}</ref> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|↑[[Hematocrit|HCT]], ↑[[PT]] and [[aPTT]], [[Eosinophilia]], [[Leukocytosis]] | |||
|↓[[Glomerular filtration rate|GFR]], ↑[[Blood urea nitrogen|BUN]], ↑[[Cr]] | |||
|Not applicable | |||
|Not applicable | |||
|↑[[Lactate]] | |||
|[[Liver function tests|LFT]], ↑[[BNP]], ↑[[Troponin]], [[D-dimer]], [[Fibrinogen]] | |||
|[[Pulmonary embolism]], [[Pericardial effusion]], [[Cardiac tamponade]], [[Pneumothorax]], Thoracic or [[abdominal aortic aneurysm]] in RUSH (Rapid Ultrasound for Shock and Hypotension) | |||
|[[Pneumonia]], [[Pneumothorax]], [[Pulmonary edema]], Widened [[mediastinum]], Free air under the [[diaphragm]] | |||
|Traumatic brain injury, [[Stroke]], Spinal injury, [[Pneumonia]], [[Pneumothorax]], Ruptured [[aneurysm]], [[Aortic dissection]], [[Pulmonary embolism]] | |||
|Not applicable | |||
| - | |||
| - | |||
|- | |||
! | |||
|'''[[Toxic megacolon]]<ref name="pmid5305933">{{cite journal |vauthors=Jalan KN, Sircus W, Card WI, Falconer CW, Bruce CB, Crean GP, McManus JP, Small WP, Smith AN |title=An experience of ulcerative colitis. I. Toxic dilation in 55 cases |journal=Gastroenterology |volume=57 |issue=1 |pages=68–82 |date=July 1969 |pmid=5305933 |doi= |url=}}</ref>''' | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|[[Leukocytosis]], [[Anemia]], ↑[[ESR]] and [[CRP]] | |||
|↑[[Blood urea nitrogen|BUN]], ↑[[Cr]] | |||
|↓[[Sodium|Na]] | |||
|Not applicable | |||
|Not applicable | |||
|Loss of haustra, Hypoechoic and thick bowel walls, Dilated [[colon]] > 6cm, Dilatation of ileal loops | |||
|Dilated [[colon]], Free intraperitoneal air | |||
|[[Bowel perforation]], [[Abscess]] | |||
|Not applicable | |||
|Not applicable | |||
|[[Endoscopy]] and [[colonoscopy]] | |||
| - | | - | ||
|} | |} | ||
<references /> | <references /> |
Revision as of 17:48, 11 May 2018
Etiology | Clinical manifestations | Paraclinical findings | Comments | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms and signs | Lab findings | Imaging | |||||||||||||||||||||
Fatigue/
Lethargy |
Thirst | Dizziness/
Confusion |
Muscle weakness/
cramp |
Somatic/
visceral pain |
Vomiting | Diarrhea | Tachypnea | Hematuria/
Proteinuria |
Edema | Blood indices | Renal Funtion test | Electrolytes | Urine analysis | ABG | Other | Ultrasound | X-ray | CT | MRI | Other | |||
Prerenal | Alcohol poisoning[1][2] | + | - | +/- | - | +/- | + | +/- | - | - | - | ↑PT | ↑BUN, ↑Cr (isopropyl alcohol) | ↓Na | Not applicable | ↓HCO3 | LFT | Not applicable | Not applicable | Not applicable | Not applicable | - | Thiamine must be given to prevent Wernicke's encephalopathy |
Aspergillosis[3][4] | +/- | - | - | - | - | - | - | +/- | - | - | Not applicable | Not applicable | Not applicable | Not applicable | Not applicable | Allergy test, ↑IgE (>1000 IU/dl), Direct visualization of fungal hyphae | Not applicable | Pulmonary infiltrates, Mucus plug, Mass in the upper lobe surrounded by a crescent of air, Solitary or multiple cavities | Halo sign, Wedge-shaped pulmonary infarction, Granuloma | Not applicable | - | Polymerase chain reaction (PCR) | |
Cholera[5][6][6][7] | +/- | + | - | - | - | +/- | + | - | - | - | Leukocytosis, ↑HCT | ↑BUN, ↑Cr | ↓Na, ↑Ca, ↑Mg | Not applicable | ↑Lactate, ↓HCO3 | Stool PCR, Stool culture, Serotyping | Not applicable | Not applicable | Not applicable | Not applicable | - | - | |
Congestive heart failure (CHF)[8][9] | + | - | - | - | - | - | + | - | - | + | Anemia, Leukocytosis | ↑BUN, ↑Cr | ↓Na, ↑K | Not applicable | ↑Lactate, ↓HCO3, | ↑BNP, ↑Troponin | Cardiomegaly, Pulmonary hypertension, Pleural effusions | Pulmonary edema | Not applicable | Valvular heart disease | Decreased ejection fraction in echocardiography, Heart function and damage in nuclear imaging | - | |
Dehydration[10][11] | + | + | - | +/- | - | +/- | +/- | - | - | - | Not applicable | ↑BUN, ↑Cr | ↓Na, ↑K, ↓Cl | Ketones and glucose, ↑Urine specific gravity | ↑Lactate, ↓HCO3 | Hypoglycemia | Not applicable | Not applicable | Not applicable | Not applicable | - | - | |
Diarrhea and/or vomiting[12][13] | +/- | +/- | - | - | - | + | + | - | - | - | Leukocytosis with predominant neutrophilia, ↑ ESR | Not applicable | Not applicable | Ketones, Organic acids, Porphobilinogen, Aminolevulinic acid | Not applicable | Stool anion gap, Stool pH < 5.5, Stool culture, Serotyping, Enzyme immunoassay (rotavirus or adenovirus), LFT, Amylase, Lipase | Normal | Not applicable | Not applicable | Not applicable | - | - | |
Drugs/toxins[14][15] | +/- | +/- | +/- | +/- | +/- | +/- | +/- | +/- | +/- | +/- | Not applicable | ↑BUN, ↑Cr, ↑CK | ↑K, ↓Mg, ↓Ca, ↓P | Ingested drug, Glucose, Aminoacid, Phosphate, Ketone, Hyaline cast, RBC | ↑Lactate, Metabolic acidosis | Toxicology, Rapid immunoassay | Nephropathy | Radioopaque substances, Ingested drug packets | Not applicable | Not applicable | - | - | |
Esophageal varices bleeding[16][17] | +/- | - | - | - | +/- | - | - | - | - | - | Normocytic normochromic anemia | ↑BUN, ↑Cr | Not applicable | Not applicable | Not applicable | Not applicable | Velocity and direction of portal flow | Abnormal opacities outside ofesophageal wall, Posterior mediastinal or intraparenchymal mass, Dilated azygous vein | Entire portal venous system | Portrays esophageal varices as flow voids | Portal hypertension and esophageal varices in positron emission tomography, Flexible endoscope, Barium swallow of snake-like filling defects | - | |
Heart disease[18][19] | +/- | - | - | - | - | - | - | +/- | - | +/- | ↑ESR and CRP | ↑BUN, ↑Cr | Not applicable | Not applicable | Not applicable | Throat culture, Rapid streptococcal antigen test, Hyperoxia test, Pulse oximetry | Not applicable | Cardiomegaly, Dextrocardia | Not applicable | Not applicable | Ventricular dysfunction, Left and right ventricular hypertrophy, Valvular disease in echocardiography | - | |
Hemorrhage[20][21] | - | - | - | - | - | - | - | - | - | - | Normocytic normochromic anemia, ↑PT, ↑PTT | ↑BUN, ↑Cr | ↑Na, ↑Cl, ↓Ca | Not applicable | Metabolic acidosis | Not applicable | Peritoneal cavity fluid in FAST | Bilateral opacities in the lung field, Hemothorax, Hemoperitoneum, Ruptured abdominal aortic aneurysm | Intrathoracic, intra-abdominal, and retroperitoneal bleeding | Not applicable | Source of bleeding in the upper GI in EGD, Angiography | - | |
Hemolysis[22][23] | +/- | - | - | - | - | - | - | - | +/- | - | Thrombocytopenia, Microcytic hypochromic anemia, ↑RDW, ↑Retic count | Not applicable | Not applicable | Not applicable | Not applicable | ↑LDH, ↓Haptoglobin, ↑Unconjugated bilirubin | Hepatomegaly,Splenomegaly | Not applicable | Not applicable | Not applicable | - | - | |
Hepatorenal syndrome[24][25] | +/- | - | - | - | +/- | +/- | - | - | +/- | +/- | Leukocytosis, ↑PT | ↓GFR, ↑BUN, ↑Cr | ↓Na | Proteinuria, Na < 10 mEq/L, Urine osmolality > plasma osmolality | Not applicable | Alpha feto-protein, Cryoglobulinemia | Exclude hydronephrosis and intrinsic renal disease | Not applicable | Not applicable | Not applicable | Right ventricular preload, ventricular filling pressures, and cardiac function in echocardiography | - | |
Ischemic cardiomyopathy[26][27] | +/- | - | - | - | - | - | - | +/- | - | +/- | Anemia | ↑Cr | ↓Na, ↓K, ↓Mg | Not applicable | Not applicable | Troponin, Creatine kinase, Creatine kinase - MB, BNP | Not applicable | Abnormal cardiac silhouette | Biventricular volume, Wall motion abnormality, Myocardial perfusion, Hypertrophic cardiomyopathy | Mid-wall fibrosis in MRI | Ejection fraction ≤35%, Pulmonary embolism, Right ventricular dilation or pericardial effusion with tamponade in echocardiography | - | |
Liver cirrhosis[28][29] | +/- | - | +/- | +/- | +/- | - | - | - | - | +/- | Not applicable | Not applicable | Not applicable | Not applicable | Not applicable | LFT, Aspartate aminotransferase to platelet ratio, FibroTest/FibroSure, Hepascore, FibroSpectatio | Portal blood flow velocity, Hepatic artery enlargement, Multifocal lesions or masses, Hepatic contour, Ascites, Splenomegaly | Bowel perforation, Gynecomastia, Azygos vein enlargement, Pleural effusion | Morphologic changes in the liver, Collaterals and shunts, Hyperattenuating nodule of hepatocellular carcinoma, Portal vein thrombosis | Vacular patency, Tumor invasion, Portal vein thrombosis, Steatosis | Hepatic function and portal hypertension in nuclear imaging, Hepatic perfusion and the development of shunts and tumors in angiography | Irreversible and a transplant is usually needed | |
Malignant hypertension[30][31] | +/- | - | + | - | - | +/- | - | +/- | - | +/- | Microangiopathic hemolytic anemia | ↑BUN, ↑Cr | ↑Na, ↑K, ↑P | Proteinuria, Microscopic hematuria | Acidosis | Cardiac enzymes, Urinary catecholamines, TSH, ↑Renin | Not applicable | Cardiomegaly, Pulmonary edema, Rib notching, Aortic coarctation, Mediastinal widening, Aortic dissection | Not applicable | Not applicable | Left atrial enlargement and left ventricular hypertrophy in echocardiography | - | |
Etiology | Fatigue/
Lethargy |
Thirst | Dizziness/
Confusion |
Muscle weakness/
cramp |
Somatic/
visceral pain |
Vomiting | Diarrhea | Tachypnea | Hematuria/
Proteinuria |
Edema | Blood indices | Renal Funtion test | Electrolytes | Urine analysis | ABG | Other | Ultrasound | X-ray | CT | MRI | Other | Comments | |
Myocarditis[32] | +/- | - | - | - | +/- | - | - | +/- | - | - | Leukocytosis (eosinophilia),↑ESR and CRP | Not applicable | Not applicable | Not applicable | Not applicable | Cardiac enzymes, Viral antibodies | Not applicable | Not applicable | Not applicable | Inflammatory edema, Degree of scarring | Endomyocardial biopsy, Echocardiography, Scintigraphy | Not applicable | |
Peritonitis[33][34] | +/- | - | +/- | - | +/- | +/- | +/- | - | - | - | Leukocytosis | Not applicable | Not applicable | Not applicable | Not applicable | Ascitic fluid neutrophil count > 500 cells/µL | Not applicable | Not applicable | Not applicable | Not applicable | - | - | |
Polycythemia[35][36] | +/- | - | - | - | - | - | - | +/- | - | - | ↑RBC, ↑HCT, ↑HGB, Thrombocytosis, Leukocytosis, ↑PT and aPTT | ↓Erythropoietin | Not applicable | Not applicable | Not applicable | Hyperuricemia | Splenomegaly | Not applicable | Not applicable | Not applicable | - | Phlebotomy is the usual treatment | |
Respiratory distress syndrome[37] | + | - | +/- | - | - | - | - | + | - | - | Not applicable | Not applicable | Not applicable | Not applicable | Metabolic and respiratory acidosis | Pulse oximetry | Not applicable | Bilateral, diffuse, reticular granular or ground-glass appearance +/- Cardiomegaly | Not applicable | Not applicable | Patent ductus arteriosus in echocardiography | - | |
Shock[38] | +/- | +/- | +/- | +/- | +/- | +/- | - | +/- | +/- | - | ↑HCT, ↑PT and aPTT, Eosinophilia, Leukocytosis | ↓GFR, ↑BUN, ↑Cr | Not applicable | Not applicable | ↑Lactate | LFT, ↑BNP, ↑Troponin, D-dimer, Fibrinogen | Pulmonary embolism, Pericardial effusion, Cardiac tamponade, Pneumothorax, Thoracic or abdominal aortic aneurysm in RUSH (Rapid Ultrasound for Shock and Hypotension) | Pneumonia, Pneumothorax, Pulmonary edema, Widened mediastinum, Free air under the diaphragm | Traumatic brain injury, Stroke, Spinal injury, Pneumonia, Pneumothorax, Ruptured aneurysm, Aortic dissection, Pulmonary embolism | Not applicable | - | - | |
Toxic megacolon[39] | +/- | +/- | +/- | - | + | + | +/- | - | - | - | Leukocytosis, Anemia, ↑ESR and CRP | ↑BUN, ↑Cr | ↓Na | Not applicable | Not applicable | Loss of haustra, Hypoechoic and thick bowel walls, Dilated colon > 6cm, Dilatation of ileal loops | Dilated colon, Free intraperitoneal air | Bowel perforation, Abscess | Not applicable | Not applicable | Endoscopy and colonoscopy | - |
- ↑ Pletcher MJ, Maselli J, Gonzales R (December 2004). "Uncomplicated alcohol intoxication in the emergency department: an analysis of the National Hospital Ambulatory Medical Care Survey". Am. J. Med. 117 (11): 863–7. doi:10.1016/j.amjmed.2004.07.042. PMID 15589492.
- ↑ Cherpitel CJ (March 1989). "Breath analysis and self-reports as measures of alcohol-related emergency room admissions". J. Stud. Alcohol. 50 (2): 155–61. PMID 2927129.
- ↑ Marr KA, Carter RA, Crippa F, Wald A, Corey L (April 2002). "Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients". Clin. Infect. Dis. 34 (7): 909–17. doi:10.1086/339202. PMID 11880955.
- ↑ Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupée M, Caulet-Maugendre S, Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP (September 2006). "Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey". Clin. Infect. Dis. 43 (5): 577–84. doi:10.1086/505870. PMID 16886149.
- ↑ Weil AA, Khan AI, Chowdhury F, Larocque RC, Faruque AS, Ryan ET, Calderwood SB, Qadri F, Harris JB (November 2009). "Clinical outcomes in household contacts of patients with cholera in Bangladesh". Clin. Infect. Dis. 49 (10): 1473–9. doi:10.1086/644779. PMC 2783773. PMID 19842974.
- ↑ 6.0 6.1 Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB (January 1974). "Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum". J. Infect. Dis. 129 (1): 45–52. PMID 4809112.
- ↑ Harris JB, Ivers LC, Ferraro MJ (June 2011). "Case records of the Massachusetts General Hospital. Case 19-2011. A 4-year-old Haitian boy with vomiting and diarrhea". N. Engl. J. Med. 364 (25): 2452–61. doi:10.1056/NEJMcpc1100927. PMID 21696312.
- ↑ Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA (September 2007). "Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure". Circulation. 116 (13): 1482–7. doi:10.1161/CIRCULATIONAHA.107.696906. PMID 17724259.
- ↑ Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ (February 2005). "Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis". JAMA. 293 (5): 572–80. doi:10.1001/jama.293.5.572. PMID 15687312.
- ↑ Steiner MJ, DeWalt DA, Byerley JS (June 2004). "Is this child dehydrated?". JAMA. 291 (22): 2746–54. doi:10.1001/jama.291.22.2746. PMID 15187057.
- ↑ Vega RM, Avner JR (June 1997). "A prospective study of the usefulness of clinical and laboratory parameters for predicting percentage of dehydration in children". Pediatr Emerg Care. 13 (3): 179–82. PMID 9220501.
- ↑ Carpenter DO (February 1990). "Neural mechanisms of emesis". Can. J. Physiol. Pharmacol. 68 (2): 230–6. PMID 2178747.
- ↑ Bresee JS, Marcus R, Venezia RA, Keene WE, Morse D, Thanassi M, Brunett P, Bulens S, Beard RS, Dauphin LA, Slutsker L, Bopp C, Eberhard M, Hall A, Vinje J, Monroe SS, Glass RI (May 2012). "The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States". J. Infect. Dis. 205 (9): 1374–81. doi:10.1093/infdis/jis206. PMID 22454468.
- ↑ Toto RD, Mitchell HC, Lee HC, Milam C, Pettinger WA (October 1991). "Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis". Ann. Intern. Med. 115 (7): 513–9. PMID 1883120.
- ↑ Bismuth C, Gaultier M, Conso F, Efthymiou ML (1973). "Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications". Clin. Toxicol. 6 (2): 153–62. doi:10.3109/15563657308990513. PMID 4715199.
- ↑ Graham DY, Smith JL (April 1981). "The course of patients after variceal hemorrhage". Gastroenterology. 80 (4): 800–9. PMID 6970703.
- ↑ de Franchis R (October 2010). "Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension". J. Hepatol. 53 (4): 762–8. doi:10.1016/j.jhep.2010.06.004. PMID 20638742.
- ↑ LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH (June 1991). "Smoking and mortality among older men and women in three communities". N. Engl. J. Med. 324 (23): 1619–25. doi:10.1056/NEJM199106063242303. PMID 2030718.
- ↑ Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, Gidding SS, Beekman RH, Grosse SD (August 2009). "Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP". Pediatrics. 124 (2): 823–36. doi:10.1542/peds.2009-1397. PMID 19581259.
- ↑ Achneck HE, Sileshi B, Parikh A, Milano CA, Welsby IJ, Lawson JH (November 2010). "Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface". Circulation. 122 (20): 2068–77. doi:10.1161/CIRCULATIONAHA.110.936773. PMID 21098468.
- ↑ Gralnick HR, Rick ME, McKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y (July 1986). "Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease". Blood. 68 (1): 58–61. PMID 3487361.
- ↑ Liesveld JL, Rowe JM, Lichtman MA (March 1987). "Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases". Blood. 69 (3): 820–6. PMID 3814817.
- ↑ Marchand A, Galen RS, Van Lente F (May 1980). "The predictive value of serum haptoglobin in hemolytic disease". JAMA. 243 (19): 1909–11. PMID 7365971.
- ↑ Ginès P, Schrier RW (September 2009). "Renal failure in cirrhosis". N. Engl. J. Med. 361 (13): 1279–90. doi:10.1056/NEJMra0809139. PMID 19776409.
- ↑ Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Schölmerich J (January 1996). "Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club". Hepatology. 23 (1): 164–76. doi:10.1002/hep.510230122. PMID 8550036.
- ↑ Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (April 2006). "Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention". Circulation. 113 (14): 1807–16. doi:10.1161/CIRCULATIONAHA.106.174287. PMID 16567565.
- ↑ Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, Mellwig KP, Assanelli D, Delise P, van-Buuren F, Anastasakis A, Heidbuchel H, Hoffmann E, Fagard R, Priori SG, Basso C, Arbustini E, Blomstrom-Lundqvist C, McKenna WJ, Thiene G (March 2005). "Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology". Eur. Heart J. 26 (5): 516–24. doi:10.1093/eurheartj/ehi108. PMID 15689345.
- ↑ Ge PS, Runyon BA (March 2014). "The changing role of beta-blocker therapy in patients with cirrhosis". J. Hepatol. 60 (3): 643–53. doi:10.1016/j.jhep.2013.09.016. PMID 24076364.
- ↑ Becker CD, Scheidegger J, Marincek B (1986). "Hepatic vein occlusion: morphologic features on computed tomography and ultrasonography". Gastrointest Radiol. 11 (4): 305–11. PMID 3533689.
- ↑ Johnson W, Nguyen ML, Patel R (November 2012). "Hypertension crisis in the emergency department". Cardiol Clin. 30 (4): 533–43. doi:10.1016/j.ccl.2012.07.011. PMID 23102030.
- ↑ Elliott WJ (2006). "Clinical features in the management of selected hypertensive emergencies". Prog Cardiovasc Dis. 48 (5): 316–25. doi:10.1016/j.pcad.2006.02.004. PMID 16627047.
- ↑ Dec GW, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA (April 1985). "Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome". N. Engl. J. Med. 312 (14): 885–90. doi:10.1056/NEJM198504043121404. PMID 3974674.
- ↑ Such J, Runyon BA (October 1998). "Spontaneous bacterial peritonitis". Clin. Infect. Dis. 27 (4): 669–74, quiz 675–6. PMID 9798013.
- ↑ Runyon BA (October 1990). "Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis". Hepatology. 12 (4 Pt 1): 710–5. PMID 2210672.
- ↑ Gregg XT, Prchal JT (January 1997). "Erythropoietin receptor mutations and human disease". Semin. Hematol. 34 (1): 70–6. PMID 9025165.
- ↑ Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT (September 1997). "Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias". Blood. 90 (5): 2057–61. PMID 9292543.
- ↑ Hooper SB, Te Pas AB, Kitchen MJ (May 2016). "Respiratory transition in the newborn: a three-phase process". Arch. Dis. Child. Fetal Neonatal Ed. 101 (3): F266–71. doi:10.1136/archdischild-2013-305704. PMID 26542877.
- ↑ Vincent JL, De Backer D (October 2013). "Circulatory shock". N. Engl. J. Med. 369 (18): 1726–34. doi:10.1056/NEJMra1208943. PMID 24171518.
- ↑ Jalan KN, Sircus W, Card WI, Falconer CW, Bruce CB, Crean GP, McManus JP, Small WP, Smith AN (July 1969). "An experience of ulcerative colitis. I. Toxic dilation in 55 cases". Gastroenterology. 57 (1): 68–82. PMID 5305933.